Evidence map›Paper›PMID 28115426›Full record

ArticleMolecular and cellular biology2017

p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex.

Shasha Tao, Pengfei Liu, Gang Luo, Montserrat Rojo de la Vega, Heping Chen, Tongde Wu, Joseph Tillotson, Eli Chapman, Donna D Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. In Vivo and In Vitro Antioxidant Effects ofAntioxidants (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shasha TaoDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Pengfei LiuDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Gang LuoDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Montserrat Rojo de la VegaDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Heping ChenDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Tongde WuDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Joseph TillotsonDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Eli ChapmanDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA chapman@pharmacy.arizona.edu dzhang@pharmacy.arizona.edu.
Donna D ZhangDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA chapman@pharmacy.arizona.edu dzhang@pharmacy.arizona.edu.
University of Arizona · US

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
The protective role of Nrf2 in arsenic-induced toxicity and carcinogenicityR01ES015010 · NIEHS · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2006 to 2015
$3.4M
Stress response, p97, and Nrf2 in arsenic-mediated toxicityR01ES023758 · NIEHS · UNIVERSITY OF ARIZONA · PI CHAPMAN, ELI, ZHANG, DONNA D · 2014 to 2018
$1.6M
Investigation of an anti-cancer phytochemical targeting Nrf2R01CA154377 · NCI · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2011 to 2015
$1.5M
NCI NIH HHS R01 CA154377NIEHS NIH HHS P30 ES006694NIEHS NIH HHS R01 ES015010NIEHS NIH HHS R01 ES023758NIEHS NIH HHS T32 ES007091
6 · The paper itself

Abstract

Activation of the stress-responsive transcription factor NRF2 is the major line of defense to combat oxidative or electrophilic insults. Under basal conditions, NRF2 is continuously ubiquitylated by the KEAP1-CUL3-RBX1 E3 ubiquitin ligase complex and is targeted to the proteasome for degradation (the canonical mechanism). However, the path from the CUL3 complex to ultimate proteasomal degradation was previously unknown. p97 is a ubiquitin-targeted ATP-dependent segregase that extracts ubiquitylated client proteins from membranes, protein complexes, or chromatin and has an essential role in autophagy and the ubiquitin proteasome system (UPS). In this study, we show that p97 negatively regulates NRF2 through the canonical pathway by extracting ubiquitylated NRF2 from the KEAP1-CUL3 E3 complex, with the aid of the heterodimeric cofactor UFD1/NPL4 and the UBA-UBX-containing protein UBXN7, for efficient proteasomal degradation. Given the role of NRF2 in chemoresistance and the surging interest in p97 inhibitors to treat cancers, our results indicate that dual p97/NRF2 inhibitors may offer a more potent and long-term avenue of p97-targeted treatment.

Indexed as

UbiquitinationAdenosine TriphosphatasesCarrier ProteinsCell Cycle ProteinsCell Line, TumorCullin ProteinsHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Protein BindingProteolysisSignal TransductionUbiquitinValosin Containing ProteinAdenosine TriphosphatasesCarrier ProteinsCell Cycle ProteinsCUL3 protein, humanCullin ProteinsKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2RBX1 protein, humanUbiquitinValosin Containing Proteinautophagycancer chemoresistanceKEAP1NRF2oxidative stressp97proteasomeprotein quality controlubiquitylation

Identifiers

PMID28115426
PMCPMC5376629
OpenAlexW2580838661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.